ESMO 2025 Conference Review focus on Targeted and Emerging Therapies in NSCLC
In this edition:
BL-B01D1-LUNG-101: Iza-Bren in NSCLC
SOHO-01: sevabertinib in HER2-altered NSCLC
Beamion LUNG-1: zongertinib HER2-altered NSCLC
LOXO-RAS-20001: olomorasib in KRAS G12C-altered NSCLC with brain metastases
REZILIENT2: zipalertinib in NSCLC harbouring ex20ins/other EGFR alterations
FURMO-003: firmonertinib in NSCLC harbouring EGFR ex20ins alterations
PHAROS: 4-year OS results
HARMONi-6: ivonescimab + chemotherapy vs. tislelizumab + chemotherapy in squamous NSCLC
OptiTROP-Lung04: sac-TMT vs. chemotherapy in EGFR-altered, EGFR-TKI-resistant NSCLC
ARTEMIDE-01: rilvegostomig in NSCLC
Latest Publications and Videos
Stay up to date with our latest clinical information.
Explore Research Review Publications and Videos
Dive into our publications and videos content from over 50 areas of medicine including Cardiology, Diabetes, Oncology, Haematology and Psychiatry.
Terms and Conditions
Website terms of use
By using our website, you agree to follow these terms and conditions.
Privacy policy
We take your privacy seriously. To understand how we collect, use, and protect your information, please read our Privacy Policy, which is part of these terms.
Copyright and use of website content
The content of our website is protected by copyright, trademarks, and other legal rights. You can: view, download, or print a single copy of content for your personal or professional use.
You cannot: copy, modify, or distribute website content, or use our website content for commercial purposes or in other works without permission.
Links to third-party websites
The Research Review website may link to third-party websites for your convenience. However:
We do not endorse or approve their products, services, or actions.
We are not responsible for their content or how they operate.
There is no formal partnership between us and third parties unless we clearly state otherwise.
Disclaimer and limitation of liability
We do our best to keep the information on our website accurate, but we do not guarantee that it is always correct or up to date.
To the fullest extent allowed by law, we are not responsible for:
Any loss, damage, or costs you may suffer from using (or being unable to use) our website.
Any decisions you make based on the information provided.
Any business losses, such as lost profits, lost data, or business interruptions.
Governing law
These terms are governed by New Zealand law. If there is a dispute, it must be resolved in a New Zealand court.